Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
A comparison of dosing regimens of paricalcitol capsule for the treatment of secondary hyperparathyroidism in CKD stages 3 and 4
Hanna Abboud
,
Daniel Coyne
, Olgierd Smolenski
, Michael Anger
, Norman Lunde
, Ping Qiu
, Rich Hippensteel
, Rajendra S. Pradhan
, Rameshraja V. Palaparthy
, Anne Kavanaugh
, Joel Z. Melnick
, Laura A. Williams
, Daniel Batlle
Division of Nephrology
Institute of Clinical and Translational Sciences (ICTS)
Research output
:
Contribution to journal
›
Article
›
peer-review
22
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'A comparison of dosing regimens of paricalcitol capsule for the treatment of secondary hyperparathyroidism in CKD stages 3 and 4'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Chronic Kidney Disease Stage 3
100%
Dosing Regimen
100%
Secondary Hyperparathyroidism
100%
Paricalcitol
100%
Intact Parathyroid Hormone (iPTH)
50%
Placebo
37%
Chronic Kidney Disease Patients
37%
Pharmacokinetics
25%
Intermittent Dosing
25%
Placebo Groups
12%
Randomized Double-blind
12%
Placebo-controlled
12%
Serum Calcium
12%
Serum Phosphorus
12%
Treatment Regimen
12%
Percentage Reduction
12%
Steady State
12%
Baseline Data
12%
Hyperphosphatemia
12%
Hypercalcemia
12%
Calcitriol
12%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Kidney Failure
100%
Secondary Hyperparathyroidism
100%
Paricalcitol
100%
Placebo
62%
Parathyroid Hormone
50%
Pharmacokinetics
25%
Calcitriol
12%
Normal Human
12%
Hyperphosphatemia
12%
Hypercalcaemia
12%